| Dr Teoman R Demir, MD | |
|
10110 Donald Powers Dr, Suite 202, Munster, IN 46321-2915 | |
| (219) 922-0222 | |
| (219) 922-8899 |
| Full Name | Dr Teoman R Demir |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 10110 Donald Powers Dr, Munster, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316959695 | NPI | - | NPPES |
| 200222040 | Medicaid | IN | |
| 000000304901 | Other | IN | ANTHEM/BCBS |
| P000096383 | Other | IN | RRMEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01050109A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital | Munster, IN | Hospital |
| St Catherine Hospital Inc | East chicago, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
News Archive
Neuroendocrine tumors (NETs) are a group of rare cancers that pose unique challenges in diagnosis and treatment. In a recent issue of Pancreas, official journal of the American Pancreatic Association, presents the newly developed consensus guidelines of the North American Neuroendocrine Tumor Society (NANETS).
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Targeted immunization against bacterial flagellin, a protein that forms the appendage that enables bacterial mobility, can beneficially alter the intestinal microbiota, decreasing the bacteria's ability to cause inflammation and thus protecting against an array of chronic inflammatory diseases, according to a new study by the Institute for Biomedical Sciences and the Neuroscience Institute at Georgia State University.
› Verified 6 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
Neuroendocrine tumors (NETs) are a group of rare cancers that pose unique challenges in diagnosis and treatment. In a recent issue of Pancreas, official journal of the American Pancreatic Association, presents the newly developed consensus guidelines of the North American Neuroendocrine Tumor Society (NANETS).
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Targeted immunization against bacterial flagellin, a protein that forms the appendage that enables bacterial mobility, can beneficially alter the intestinal microbiota, decreasing the bacteria's ability to cause inflammation and thus protecting against an array of chronic inflammatory diseases, according to a new study by the Institute for Biomedical Sciences and the Neuroscience Institute at Georgia State University.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teoman R Demir, MD 10110 Donald Powers Dr, Suite 202, Munster, IN 46321-2915 Ph: (219) 922-0222 | Dr Teoman R Demir, MD 10110 Donald Powers Dr, Suite 202, Munster, IN 46321-2915 Ph: (219) 922-0222 |
News Archive
Neuroendocrine tumors (NETs) are a group of rare cancers that pose unique challenges in diagnosis and treatment. In a recent issue of Pancreas, official journal of the American Pancreatic Association, presents the newly developed consensus guidelines of the North American Neuroendocrine Tumor Society (NANETS).
Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.
Investigators at The Cancer Institute of New Jersey (CINJ) have partnered with the National Cancer Institute (NCI) and launched a clinical trial examining the effectiveness of a combined vaccine and hormone treatment for prostate cancer that is resistant to hormone therapy and not visible on imaging tests such as a CT scan and a bone scan.
Targeted immunization against bacterial flagellin, a protein that forms the appendage that enables bacterial mobility, can beneficially alter the intestinal microbiota, decreasing the bacteria's ability to cause inflammation and thus protecting against an array of chronic inflammatory diseases, according to a new study by the Institute for Biomedical Sciences and the Neuroscience Institute at Georgia State University.
› Verified 6 days ago
Raquel Elisa Redondo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9800 Valparaiso Dr, Munster, IN 46321 Phone: 219-934-9800 Fax: 219-924-8831 | |
Dr. Devendra Desai, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-7214 Fax: 219-836-5842 | |
Kayla Marie Kralovec, NP Surgery Medicare: Medicare Enrolled Practice Location: 9800 Valparaiso Dr, Munster, IN 46321 Phone: 219-934-9852 Fax: 219-836-7593 | |
Dr. Creighton M Rawlings, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 7905 Calumet Ave, Hammond Clinic Llc, Munster, IN 46321 Phone: 219-836-7214 Fax: 219-836-5842 | |
Dr. Russell W Pellar, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 10110 Donald Powers Dr, Suite 202, Munster, IN 46321 Phone: 219-922-0222 Fax: 219-922-8899 | |
Dr. Anne Therese Dempsey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10110 Donald Powers Dr., Suite 202, Munster, IN 46321 Phone: 219-922-0222 Fax: 219-922-8899 |